Laryngeal Squamous Cell Carcinoma
Also known as: Squamous Cell Carcinoma (SCC) of the Larynx / Squamous Cell Carcinoma of the Larynx / Squamous Cell Carcinoma of Larynx / Larynx Squamous Cell Carcinoma / Primary squamous cell carcinoma of larynx (disorder) / Squamous cell carcinoma of larynx (disorder)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01156 | Bupropion | 0 | Terminated | 1 |
DB00184 | Nicotine | 0 | Terminated | 1 |
DB01273 | Varenicline | 0 | Terminated | 1 |
DB11714 | Durvalumab | 1 | Active Not Recruiting | 1 |
DB05643 | IRX-2 | 1 | Active Not Recruiting | 1 |
DB00002 | Cetuximab | 1 / 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 / 2 | Active Not Recruiting | 1 |
DB18446 | RAPA-201 | 1 / 2 | Recruiting | 1 |
DB00877 | Sirolimus | 1 / 2 | Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 2 | Active Not Recruiting | 2 |
DB00958 | Carboplatin | 2 | Not Yet Recruiting | 1 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB14707 | Cemiplimab | 2 | Withdrawn | 1 |
DB14547 | Chloride ion | 2 | Active Not Recruiting | 1 |
DB14547 | Chloride ion | 2 | Not Yet Recruiting | 1 |
DB14547 | Chloride ion | 2 | Recruiting | 1 |
DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 2 | Not Yet Recruiting | 2 |
DB00515 | Cisplatin | 2 | Recruiting | 1 |
DB01248 | Docetaxel | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 2 |
DB09037 | Pembrolizumab | 2 | Not Yet Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB12257 | Platinum | 2 | Active Not Recruiting | 1 |
DB12257 | Platinum | 2 | Not Yet Recruiting | 1 |
DB12257 | Platinum | 2 | Recruiting | 1 |
DB02546 | Vorinostat | 2 | Not Yet Recruiting | 1 |
DB16305 | Xevinapant | 2 | Not Yet Recruiting | 1 |
DB00002 | Cetuximab | 2 / 3 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 2 / 3 | Active Not Recruiting | 1 |